|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | |
| A61P 13/12 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3304086 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16802790.2 |
| Europos patento paraiškos padavimo data | 2016-05-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2016/002562 |
| Data | 2016-05-27 |
| (87) | Numeris | WO 2016/194348 |
| Data | 2016-12-08 |
| (30) | Numeris | Data | Šalis |
| 201562167964 P | 2015-05-29 | US |
| (72) |
FUNAHASHI, Yasuhiro, JP
KADOWAKI, Tadashi, JP
|
| (73) |
Eisai R&D Management Co., Ltd.,
4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | METHOD FOR PREDICTING RESPONSIVENESS TO A COMBINATION THERAPY WITH LENVATINIB AND EVEROLIMUS |
| METHOD FOR PREDICTING RESPONSIVENESS TO A COMBINATION THERAPY WITH LENVATINIB AND EVEROLIMUS |